On the scent of a smoker's `fix'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Trying to give up smoking, but still craving a cigarette? American researchers have charted the effects of a mystery chemical in cigarette smoke that seems to act with nicotine to give smokers a "high".
Nicotine is addictive, but the new research shows that there are other components in cigarette smoke which have a similar effect on the brain to drugs such as heroin and cocaine.
Joanna Fowler, a chemist at Brookhaven National Laboratory in New York, and her colleagues have not identified the new chemical, but have monitored its effects by studying scans of the brains of both smokers and non-smokers.
They found that it acts indirectly on dopamine, a chemical messenger that carries signals between nerves and affects mood. Dopamine has been implicated in the "rewarding properties" of drugs of abuse.
The study, published in today's issue of the journal Nature, could explain why cigarettes are so addictive and expose tobacco as a so-called "gateway" drug, making people more susceptible to addiction. It may also shed some light on the finding that smokers seem to suffer less than the norm from Parkinson's Disease.
Dr Fowler and her colleagues discovered that smokers have lower concentrations of the chemical monoamine oxidase (MAO) B in their brains than ex- or non-smokers.
This chemical breaks down dopamine, so if the concentrations of MAO are reduced by cigarette smoke, levels of dopamine are increased - leading to the rewarding, addictive effect of tobacco smoke.
Dr Fowler said this was the first such study on living volunteers. "It's amazing how little is known about the effects of smoke on the brain," she said.
French researchers reported last year that they were using an antidepressant which inhibits MAO to help smokers quit. MAO inhibitors are also used to treat Parkinson's, a disease that causes uncontrollable shaking and which is associated with low levels of dopamine.
Dr Fowler has noted that depressed and schizophrenic people are likely to smoke. "There is some speculation that people who smoke and who are depressed are self-medicating," she said.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments